Florence Gattacceca

991 total citations
33 papers, 809 citations indexed

About

Florence Gattacceca is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Florence Gattacceca has authored 33 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Infectious Diseases. Recurrent topics in Florence Gattacceca's work include RNA Interference and Gene Delivery (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Florence Gattacceca is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Florence Gattacceca collaborates with scholars based in France, United States and Portugal. Florence Gattacceca's co-authors include Mansoor M. Amiji, Bruno Sarmento, Dylan Morrissey, Shanthi Ganesh, Arun K. Iyer, Jing Xu, Maxime Lehmann, Harkiranpreet Kaur Dhaliwal, Amine Sadok and Hervé Kovacic and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and International Journal of Cancer.

In The Last Decade

Florence Gattacceca

30 papers receiving 800 citations

Peers

Countries citing papers authored by Florence Gattacceca

Since Specialization

Citations

This map shows the geographic impact of Florence Gattacceca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Gattacceca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Gattacceca more than expected).

Fields of papers citing papers by Florence Gattacceca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Gattacceca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Gattacceca. The network helps show where Florence Gattacceca may publish in the future.

Co-authorship network of co-authors of Florence Gattacceca

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Gattacceca. A scholar is included among the top collaborators of Florence Gattacceca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Gattacceca. Florence Gattacceca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and synthesis of novel thioether analogs as promising antiviral agents: In vitro activity against enteroviruses of interest 2025 ·European Journal of Medicinal Chemistry ·(unknown), Franck Touret, Antonio Coluccia, (unknown), (unknown), Carole Di Giorgio, Florence Gattacceca, (unknown), Romano Silvestri, Patrice Vanelle, Manon Roche	0
2	Cross-Species Extrapolation of Neonatal Fc Receptor (FcRn) Binding Affinity to Predict Monoclonal Antibody Pharmacokinetics in Humans Using Physiologically Based Pharmacokinetic Modeling (PBPK): Are We There Yet? 2025 ·ACS Pharmacology & Translational Science ·(unknown), (unknown), Florence Gattacceca, Erik Sjögren, Laurent Nguyen, Donato Teutonico	0
3	Physiologically Based Pharmacokinetic Model of Cefotaxime in Patients with Impaired Renal Function 2025 ·Clinical Pharmacokinetics ·(unknown), (unknown), Lionel Velly, Olivier Blin, Romain Guilhaumou, Florence Gattacceca	1
4	National reflection on organs-on-chip for drug development: New regulatory challenges 2023 ·Toxicology Letters ·(unknown), Paul Houeto, Florence Gattacceca, (unknown), Danièle Debruyne, Michel Guerbet, Joël Guillemain, Isabelle Fabre, (unknown), (unknown)	9
5	Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique 2022 ·Journal of Controlled Release ·(unknown), (unknown), (unknown), Grégory Hilairet, (unknown), Jérôme Bejaud, Patrick Saulnier, Frédéric Lagarce, Florence Gattacceca, Samuel Legeay, Emilie Roger	16
6	Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimen 2021 ·Cancer Chemotherapy and Pharmacology ·(unknown), Dominique Barbolosi, (unknown), N. Tubiana-Mathieu, Marc Ychou, Alexandre Evrard, Florence Gattacceca	2
7	Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients 2020 ·British Journal of Clinical Pharmacology ·(unknown), Minh Lê, Naïm Bouazza, Florence Gattacceca, Yazdan Yazdanpanah, Catherine Dhiver, Sylvie Brégigeon, Saadia Mokhtari, Gilles Peytavin, Catherine Tamalet, Diane Descamps, Bruno Lacarelle, Caroline Solas	9
8	Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine 2020 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), Elisa A. M. Calvier, David Fabre, Florence Gattacceca, Sonia Khier	49
9	Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles 2019 ·Journal of Controlled Release ·Flávia Sousa, Harkiranpreet Kaur Dhaliwal, Florence Gattacceca, Bruno Sarmento, Mansoor M. Amiji	103
10	Population pharmacokinetics of FOLFIRINOX: a review of studies and parameters 2018 ·Cancer Chemotherapy and Pharmacology ·(unknown), Dominique Barbolosi, Florence Gattacceca	24
11	Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity 2017 ·PLoS ONE ·Alexis Courbet, Nicole Bec, (unknown), Christian Larroque, Martine Pugnière, Safia El Messaoudi, (unknown), Sonia Khier, Carine Deleuze‐Masquéfa, Florence Gattacceca	20
12	Comparative pharmacokinetics and tissue distribution analysis of systemically administered 17-β-estradiol and its metabolites in vivo delivered using a cationic nanoemulsion or a peptide-modified nanoemulsion system for targeting atherosclerosis 2014 ·Journal of Controlled Release ·(unknown), (unknown), Florence Gattacceca, Mansoor M. Amiji	13
13	In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles 2013 ·Journal of Controlled Release ·Shanthi Ganesh, Arun K. Iyer, Florence Gattacceca, Dylan Morrissey, Mansoor M. Amiji	120
14	CNS Delivery and Pharmacokinetic Evaluations of DALDA Analgesic Peptide Analog Administered in Nano-Sized Oil-in-Water Emulsion Formulation 2013 ·Pharmaceutical Research ·Lipa Shah, Florence Gattacceca, Mansoor M. Amiji	14
15	Additional Cytotoxic Pyridoacridine Alkaloids from the Ascidian Cystodytes violatinctus and Biogenetic Considerations 2013 ·Journal of Natural Products ·Nataly Bontemps, Florence Gattacceca, Christophe Long, Olivier P. Thomas, Bernard Banaigs	25
16	Metabolism and Pharmacokinetics of EAPB0203 and EAPB0503, Two Imidazoquinoxaline Compounds Previously Shown to Have Antitumoral Activity on Melanoma and T-Lymphomas 2010 ·Drug Metabolism and Disposition ·Sonia Khier, Florence Gattacceca, Safia El Messaoudi, (unknown), Carine Deleuze‐Masquéfa, Jacques Bompart, Jean‐François Cooper, Isabelle Solassol, Frédéric Pinguet, Pierre‐Antoine Bonnet, Françoise Bressolle	12
17	Pharmacokinetic properties and metabolism of a new potent antimalarial N-alkylamidine compound, M64, and its corresponding bioprecursors 2010 ·European Journal of Pharmaceutical Sciences ·(unknown), Florence Gattacceca, Georges Moarbess, Sharon Wein, Christophe Tran Van Ba, (unknown), Olivier Berger, Roger Escale, Henri Vial, Françoise Bressolle	3
18	Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma 2009 ·European Journal of Pharmaceutical Sciences ·Sonia Khier, Carine Deleuze‐Masquéfa, Georges Moarbess, Florence Gattacceca, (unknown), (unknown), Jean‐François Cooper, Frédéric Pinguet, Pierre‐Antoine Bonnet, Françoise Bressolle	22
19	Nox1-dependent superoxide production controls colon adenocarcinoma cell migration 2007 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Amine Sadok, Véronique Bourgarel‐Rey, Florence Gattacceca, Claude Penel, Maxime Lehmann, Hervé Kovacic	84
20	Nox1 downstream of 12‐lipoxygenase controls cell proliferation but not cell spreading of colon cancer cells 2007 ·International Journal of Cancer ·Daniela D. de Carvalho, Amine Sadok, Véronique Bourgarel‐Rey, Florence Gattacceca, Claude Penel, Maxime Lehmann, Hervé Kovacic	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact